CLB Stock-Based Compensation
Core Laboratories Inc · Stock-Based Compensation
CLB Stock-Based Compensation
Latest reported$8.37Mperiod ending
CLB TTM Stock-Based Comp ($0.00 → $8.37M)
TTM stock-based compensation
High-resolution chart · PNG
CLB stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,374,000 | |
| 8,010,000 | |
| 7,137,000 | |
| 5,565,000 | |
| 2,339,000 | |
| 1,669,000 | |
| 2,330,000 | |
| 4,353,000 | |
| 8,322,000 | |
| 9,807,000 | |
| 13,971,000 | |
| 12,710,000 | |
| 12,875,000 | |
| 10,513,000 | |
| 7,756,000 | |
| 7,452,000 | |
| 13,778,000 | |
| 14,787,000 | |
| 12,965,000 | |
| 4,105,000 | |
| -1,596,000 | |
| 1,269,000 | |
| 7,394,000 | |
| 19,481,000 | |
| 19,933,000 | |
| 20,313,000 | |
| 20,879,000 | |
| 33,313,000 | |
| 36,143,000 | |
| 38,999,000 | |
| 34,194,000 | |
| 24,152,000 | |
| 23,771,000 | |
| 23,510,000 | |
| 22,942,000 | |
| 22,640,000 | |
| 22,555,000 | |
| 22,340,000 | |
| 22,079,000 | |
| 22,077,000 | |
| 21,889,000 | |
| 21,533,000 | |
| 21,279,000 | |
| 20,937,000 | |
| 20,301,000 | |
| 20,399,000 | |
| 20,470,000 | |
| 20,615,000 | |
| 20,996,000 | |
| 20,667,000 | |
| 20,526,000 | |
| 20,286,000 | |
| 19,654,000 | |
| 19,131,000 | |
| 18,381,000 | |
| 17,327,000 | |
| 20,145,000 | |
| 19,031,000 | |
| 17,165,000 | |
| 15,842,000 | |
| 10,604,000 | |
| 9,426,000 | |
| 8,517,000 | |
| 7,651,000 | |
| 7,108,000 | |
| 6,187,000 | |
| 5,896,000 | |
| 4,261,000 | |
| 2,624,000 | |
| 2,630,000 | |
| 2,135,000 | |
| 2,135,000 | |
| 2,135,000 | |
| 827,000 | |
| 1,148,000 | |
| 1,148,000 | |
| 1,148,000 | |
| 1,148,000 | |
| 1,399,000 | |
| 1,399,000 | |
| 1,399,000 | |
| 1,399,000 | |
| 985,000 | |
| 985,000 | |
| 985,000 | |
| 985,000 | |
| 1,201,000 | |
| 1,201,000 | |
| 1,201,000 | |
| 1,201,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |